InvestorsHub Logo
icon url

BearNaked

04/25/19 2:09 PM

#4274 RE: Don'tDrinkTheKoolAid #4273

Reinforcing opinion... definitely appears to be in accumulation mode. No evidence we will dropping back below 2 for a maintained period.

Did not hold that same opinion of the stock on previous runs. Feb-today news has justified value and provides enough future promise to lock current level.
icon url

Dante Fantasia

04/25/19 3:49 PM

#4280 RE: Don'tDrinkTheKoolAid #4273

Today's news "wasn't blockbuster"? I must disagree on that point:

Christine Seward was a big wig over at Myriad, which as a common thread, is also a Salt Lake City Genetics company. These guys had their fingers in a ton of cancer work--they had people working at MD Anderson(where I was for a short while on an ovarian project and can vow--they are top-notch) and UT Oncology. They seem particularly well specialized (but not exclusively in) the primary areas of assessing genetic prostate cancer risk, and various cancers affecting women's health. It's a 2.5 billion dollar company (give or take on the day), and interestingly, quit just before Myriad is presenting at several sessions at the American College of Obstetricians and Gynecologists, the first week of this May in Nashville. She does the marketing/sales so is not published. My guess is she worked w/Alexander Ford, who was a women's health exec at Novartis, Aventis, Pfizer etc. and on, yup, founding board member of BioUtah. There's a lot of very impressive background at Myriad that can be found on their website, though she seems to have been wiped clean. But, again, they seem all tied together in the Salt Lake City Genetic Brotherhood. Seems like PRED is tying them all together:
https://myriad.com/


Lesa Nelson? They just kind of dropped her in because no-biggie she pretty much set-up Taurett with Ward, but have you seen her publications? She was assistant director of the University of Utah's DNA Diagnostic lab in their Reproductive Genetics Division. Lot's of work in gene mapping and identifying chromosome linkages, holds a few patents and has many pubs with a heavy focus on predicting scoliosis. There's many L Nelson's in PubMed, but I'll check a few here of her pubs here and you can search the rest.
https://www.ncbi.nlm.nih.gov/pubmed/?term=Nelson+L%5BAuthor%5D+scoliosis

So, in whole, yeah, I'd actually call this news "Blockbuster"--just a quiet one. Look at wtf PRED is doing--putting all the Utah pieces in place, and tying all these independent labs together into a critical mass before letting it rip. This is kind of starting to smell like a cancer play as well...hence the emphasis on tissue beyond simple regeneration. Huge.